Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT07583446
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 600 participants
- Sponsor
- Seismic Pharmaceuticals Operations LLC
- Registry
-
NCT07583446
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Armenia
- Registry status
- Recruiting
Technical summary
Registry record NCT07583446. Randomized; quadruple masking; primary purpose treatment. Start 2026-09-09 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
- Acronym
- RESCUE HF-CS
- Condition
- Cardiogenic Shock
- Intervention (Drug)
- istaroxime
- Intervention (Drug)
- placebo
- Lead sponsor
- Seismic Pharmaceuticals Operations LLC
Record details
- Record id
cardio:ct-nct07583446- Content hash
43b2a51f3a97f22ff0e9e05e043ddfa73f8029430bbdc3dbc15c463261b242d0